Nat. Rev. Cardiol. doi: /nrcardio

Slides:

Advertisements

Similar presentations

Nat. Rev. Cardiol. doi: /nrcardio

Advertisements

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Different manifestations of myocardial ischaemia

Figure 5 Schematic illustration of different clinical trial designs

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Mechanisms of metastatic growth in the heart

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 4 Precision prescribing

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Three-year survival rates on the basis of body composition

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 10 Lipomatous hypertrophy of the atrial septum

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Proposed clinical approach in athletes

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Health-care system today

Figure 2 Determination of phase values

Figure 1 Cardiovascular risk and disease across the life-course

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 PCI strategies in patients with STEMI and multivessel disease

Figure 6 Proposed arrhythmogenic right ventricular

Figure 1 Decision tree integrating the assessment,

Figure 2 Global cost of HF per capita in 2012

Figure 2 A patient with aortic stenosis and mitral regurgitation

Figure 5 Examples of biomarker-guided trials

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Milestones in coronary angioplasty

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Absolute difference in seasonal peak

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Observational studies on multiple treatment strategies

Figure 5 Bioresorbable vascular scaffold apposition and strut coverage

Figure 5 Rotors, wavebreak, and multiple circuit re-entry

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 U‑shape relationship between exercise dose and risk of atrial fibrillation (AF) Figure 3 | U-shape relationship between exercise dose and risk.

Figure 6 The neurogenic components of angina

Figure 1 Essential features and goals of a precision medicine system

Figure 3 Enrichment strategies for clinical trials

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Electrocardiogram patterns associated with Brugada syndrome

Figure 1 Timing of the effects of deep brain stimulation

Figure 2 Impaired mitochondrial capacity and function in heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Figure 1 Novel markers of increased stroke risk in AF

Presentation transcript:

Nat. Rev. Cardiol. doi:10.1038/nrcardio2015.194 Figure 2 Disconnect between the mechanisms and the clinical treatment of AF, and the proposed strategy to overcome it Figure 2 | Disconnect between the mechanisms and the clinical treatment of AF, and the proposed strategy to overcome it. Comparison of the current approach to atrial fibrillation (AF) management, which is disconnected from the established insights into AF pathophysiology, and the proposed approach to AF management in which the major changes leading to AF will lead to a classification of patients with AF and provide a basis for personalized prevention and management. ECG, electrocardiogram. Fabritz, L. et al. (2015) Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment Nat. Rev. Cardiol. doi:10.1038/nrcardio2015.194